fbpixel

Our website uses cookies to help enhance your browsing experience. Continue to browse our site if you agree to our use of cookies as described in Unilab's Cookie Policy .

For information on how we protect your privacy, please read our Privacy Policy .

Klindex Capsule
Formulation
Each capsule contains:
Clindamycin (as hydrochloride) 150 mg or 300 mg

Clindamycin Hydrochloride

Klindex® Capsule

Prescription Drug

Indication

  • For the treatment of serious infections caused by susceptible microorganisms:
  • Lower respiratory tract infections including bronchitis, pneumonia, empyema, and lung abscess
  • Upper respiratory tract infections including tonsillitis, pharyngitis, sinusitis, otitis media, and scarlet fever
  • Skin and skin structure infections including inflammatory acne vulgaris, furuncles, cellulitis, impetigo, abscesses, and contaminated wounds. For specific skin and skin structure infections such as erysipelas and paronychia (panaritium), it would seem logical that these conditions would respond very well to clindamycin therapy.
  • Gynecological infections including endometritis, pelvic cellulitis, post-surgical vaginal cuff infection, nongonococcal tubo-ovarian abscess, salpingitis and pelvic inflammatory disease when given in conjunction with an antibiotic of appropriate Gram-negative aerobic spectrum.

In cases of cervicitis due to Chlamydia trachomatis, monotherapy with clindamycin has been shown to be effective in eradicating the organism.

  • Intra-abdominal infections including peritonitis and abdominal abscess when given in conjunction with an antibiotic of appropriate Gram-negative aerobic spectrum
  • Bone and joint infections including acute hematogenous osteomyelitis and septic arthritis
  • Septicemia and endocarditis: The effectiveness of clindamycin in the treatment of selected cases of endocariditis has been documented when clindamycin is determined to be bactericidal to the infecting organisms by in vitro testing of appropriate achievable serum concentrations.
  • Dental infections such as periodontal abscess and periodontitis
  • Pneumocystis jiroveci (carinii) pneumonia in patients with acquired immunodeficiency syndrome (AIDS). In patients who are intolerant to or do not respond to conventional treatment, clindamycin in combination with primaquine has been shown to be efficacious.
  • As an alternative treatment of multi-drug resistant Plasmodium falciparum infection when used in combination with quinine or amodiaquine.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.